Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Finasteride effectively treats BPH by reducing prostate size and improving symptoms.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Compound 4 is a promising treatment for hair loss with low toxicity.

A new compound effectively inhibits human 5α-reductase 1.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Finasteride may help treat BPH by affecting certain biological markers.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Finasteride's molecular properties and active sites were identified using computational methods.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

The new compound may be a safer alternative to finasteride for prostate protection.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Finasteride may affect PNMT, causing side effects.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Finasteride may help some male chronic pelvic pain patients, but more research needed.